The estimated Net Worth of Joseph H. Iv Griffith is at least $1.26 million dollars as of 26 March 2024. Mr Griffith owns over 8,437 units of 908 Devices stock worth over $326,095 and over the last 4 years he sold MASS stock worth over $933,017.
Mr has made over 14 trades of the 908 Devices stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 8,437 units of MASS stock worth $13,330 on 26 March 2024.
The largest trade he's ever made was exercising 49,898 units of 908 Devices stock on 8 September 2021 worth over $27,943. On average, Mr trades about 9,494 units every 56 days since 2020. As of 26 March 2024 he still owns at least 93,437 units of 908 Devices stock.
You can see the complete history of Mr Griffith stock trades at the bottom of the page.
Joseph H. Griffith IV is the CFO & Treasurer at 908 Devices.
Mr IV is 46, he's been the CFO & Treasurer of 908 Devices since . There are 4 older and no younger executives at 908 Devices. The oldest executive at 908 Devices Inc. is Michael S. Turner Esq., J.D., 54, who is the VP, Sec. & Gen. Counsel.
Joseph's mailing address filed with the SEC is C/O 908 DEVICES INC., 645 SUMMER STREET, BOSTON, MA, 02210.
Over the last 4 years, insiders at 908 Devices have traded over $16,182,689 worth of 908 Devices stock and bought 826,585 units worth $15,798,345 . The most active insiders traders include Keith Crandell, Kevin J. Knopp et E Kevin Hrusovsky. On average, 908 Devices executives and independent directors trade stock every 10 days with the average trade being worth of $64,663. The most recent stock trade was executed by Christopher D. Brown on 7 August 2024, trading 6,328 units of MASS stock currently worth $9,998.
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
908 Devices executives and other stock owners filed with the SEC include: